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We have evaluated the capacity of dendritic ceUs to function as antigen-presenting cells (APCs)
for influenza and have examined their mechanism of action. Virus-pulsed dendritic cells were
100 times more ef~dent than bulk spleen ceUs in stimulating cytotoxic T lymphocyte (CTL)
formation. The induction of CTLs required neither exogenous lymphokines nor APCs in the
responding T cell population. Infectious virus entered dendritic cells through intraceUular acidic
vacuoles and directed the synthesis of several viral proteins. If ultravidet (UV)-inactivated or
bromdain-treated viruses were used, viral protein synthesis could not be detected, and there was
poor induction of CTLs. This indicated that dendritic cells were not capable of processing
noninfectious virus onto major histocompatibility complex (MHC) class I molecules. However,
UV-inactivated and bromdain-treated viruses were presented ef~dently to class II-restricted
CD4 + T ceils. The CD4 + T cells crossreacted with different strains of influenza and markedly
amplified CTL formation. Cell lines that lacked MHC class II, and consequently the capacity
to stimulate CD4 + T cells, failed to induce CTLs unless hdper lymphokines were added.
Similarly, dendritic cells pulsed with the MHC class I-restricted nucleoprotdn 147-155 peptide
were poor stimulators in the absence of exogenous hdper factors. We condude that the function
of dendritic cells as APCs for the generation of virus-spedfic CTLs in vitro depends measurably
upon: (a) charging class I molecules with peptides derived from endogenously synthesized viral
antigens, and (b) stimulating a strong CD4 + helper T cell response.

part of the host defense against influenza, MHC class
I-restricted CD8 + CTLs are generated that kill virusA
infected targets. Whereas neutralizing antibodies recognize
the highly variable envelope glycoproteins of the virus, CTLs
are directed primarily against highly conserved internal proteins

like the nucleoprotein (NP). 1 As a result, most influenzaspecific CTLs are broadly crossreactive and kill target cells
infected with viruses bdonging to different subtypes (1-4).
By diminating infected cells before infectious viral progeny
can be released, these killer cells appear to be important in
recovery from infection. In mice, adoptivdy transferred CTLs
can promote viral clearance and can protect against lethal infection (5-7). In infected humans, McMichad et al. (8) noted
a negative correlation between CTL activity and lung virus
titers.

1 Abbreviations used in thispaper: HA, hemagglutinin; NP, nuchoprotein;
PD, phosphate saline.
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The study of virus-specific CTLs has yielded several key
concepts in cell-mediated immunity. Using these CTLs,
Zinkernagel and Doherty (9, 10) first demonstrated the presentation of antigens in association with products of genes
within the MHC. Subsequently, Townsend et al. (11) demonstrated the recognition of processed influenza proteins or peptides by class I-restricted T cells, providing a basis for the
corecognition of antigen and MHC. Virus-specific CTL
systems helped two different pathways for antigen processing,
one exogenous and the other endogenous (12). Internalized
exogenous afitigens undergo acid-dependent degradation in
endocytic vacuoles, and peptides generated in this manner
are presented in association with MHC class II molecules to
CD4 + CTLs. In contrast, viral antigens synthesized within
cells are most likely processed within the cytoplasm, and the
immunogenetic peptides are presented with newly synthesized class I MHC molecules to CD8 + CTLs.
These studies on the recognition of viral antigens by CTLs
have relied upon activated or chronically stimulated T cells.
Less is known about the generation of functional class I-re-
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Summary

Materials and Methods
M/c~ Maleor female(BALB/c x DBA/2)Ft (C x D2; H-2a),
(C3H x DBA/2)F~ (C3D2; H-2 k x H-2a), C3H (H-2~), and
DBA/2 (H-2a) mice, 6-8 wk of age, were purchased from the
Trudeau Institute (SaranacLake,NY). To prime with influenzavirus,
the animals were anesthetized with metofane, and 5 hemagglutination units (HAU) of NT60 virus in a volume of 50/zl were applied to the nosepad. The mice were kept in a specific pathogenfree facility and used 3-6 wk later.
Virus. The PK8 (A/Puerto Rico/8/1934; H1N1 subtype) and
NT60 (A/Northern Territory/60/1968; H3N2 subtype) strainswere
kindly provided by Dr. P. Palese (Mount Sinai School of Medicine,
New York) and were grown in the allantoic cavity of 10-d erabryohated chicken eggs (SPAFAS, Norwich, CT). The allantoic fluid
was harvested after 2 d and stored at -70~ To purify the virus,
the allantoic fluid was centrifuged at 100,000 g for 2 h at 4~
The virus pellet was resuspended in SM buffer (0.1 M NaC1, 0.05
M Tris, 10 mM MgSO4, pH 7.4), layeredon a 10/35/45% cesium
chloride step gradient (Bethesda Research Laboratories, Gaithersburg, MD) in SM buffer, and centrifuged in a rotor (SW41;
Beckman Instruments, Inc., Fulhrton, CA) at 22,000 rpm for 2h
at 4~ After centrifugation the virus band at the 10 and 35%
interface was collected, diluted in phosphate saline (PD), and
pelleted. The virus pellet was then resuspended in PD and stored
in aliquots at -70~
The enzyme bromelain (Sigma Chemical Co., St. Louis, MO)
was used to remove hemagglutinin (HA) and neuraminidase glycoproteins from the virus particle (24). Pelleted virus, prepared as
above, was resuspended in bromdain buffer (0.1 M Tris, pH 7.2,
with 0,05 M/3-mercaptoethanol and 0.001 M EDTA) at a viral
protein concentration of 0.2 mg/ml, and bromelain at 2 mg/ml.
After an 18-20-h incubation at 37~ the virus was diluted in PD
and pelleted. The pelleted virus was resuspendedin a small volume
of PD and applied to a CsCI step gradient as above. Virus cores
were collected from the interface between the 10 and 35% layers,
pelleted, resuspended in PD, and stored in aliquots at -70~
Removal of the HA was confirmed using a hemagglutination assay.
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Virus was inactivatedby diluting the allantoicfluid 1:10in HBSS
with Ca2+ and Mg2+, and exposing it to shortwave UV radiation
from a Mineralight UV lamp (UVGL58; Ultraviolet Products, San
Gabriel, CA) for 10 min at a distance of 10 cm with constant stirring. V'trusinactivationwas confirmedwith a modifiedphque assay.
CultureMedium. The culture medium for cells was RPMI 1640
(Gibco Laboratories, Grand Island, NY) containing 5% heatinactivated FCS (JRH-Biosciences,Lenexa,KS), 2 mM glutamine,
100 IU/ml penicillin, 100/~g/ml streptomycin, 100/~g/ml gentamicin, and 10/zM 3-mercaptoethanol.
Responder T Cells. Spleencell suspensions were prepared and
passed over nylon wool columns (Polysciences,Inc., Warrington,
PA). T cellswere further purifiedby labelingthe nylon wool-nonadherent cells with rat mAbs from the American Type Culture Collection (ATCC; Rockville, MD) (B21-2, anti-Ia; M1/70, anti-Mac
1; RA3-6B2.1, anti-B220) and two rounds of panning. Bacteriologicalplates (FalconLabware,Oxnard, CA) were coated with goat
anti-rat IgG (H + L) (Kirkegaard & Perry Laboratories, Inc.,
Gaitherburg, MD) at 10/~g/ml for 1 h at room temperature and
washed. The cells were added and the pans centrifuged in a centrifuge (RC-3B; Sorvall) at 500 rpm for 5 min. After this spin,
the plates were swirled, rotated 180~, and centrifuged again. The
cells were harvested by gently washing the plates with cold RPMI.
T cells prepared in this manner were 85-90% Thy-l+. Depletion
of APCs was evident by the fact that the T cells did not respond
to stimulation with anti-CD3 mAb or with Con A.
To prepare CD4 § or CD8 + T cell subsets, nylon wool-nonadherent cells were treated with complement (Pel-FreezeBiologicals,
Rogers, AK) plus anti-Iab,a (B21-2) and either anti-CD8 mAbs
(TIB 150 and TIB 211; ATCC) or anti-CD4 mAb (GK1.5). CD8 §
T cells were further purified by labeling the complement-treated
cells with a FITC rat anti-mouse CD8 (Becton Dickinson & Co.,
Mountain View, CA) at 0.2/~g/ml and then sorting positively
stained cells in a FACStar Plus| instrument (Becton Dickinson &
Co.). Cells prepared with this protocol were >98% CD8 +.
APCs. Spleens were injected with 100 U/ml coLlagenaseD
(Boehringer Mannheim Biochemicals,Indianapolis,IN) and teased
apart with forceps (25). The released cells were transferred to a
tube and the remainingfragmentsincubatedin 400 U/ml collagenase
for 45-60 rain at 37~ After this incubation, the spleen fragments
were passed through a steel mesh, and the cells were pooled with
the cells collected earlier and centrifuged. The resuhing pellet was
resuspended in dense BSA (p = 1.080) and centrifuged in a rotor
(HS-4; Sorvall) at 7,000 rpm (9,500 g) for 15 rain. The dendritic
cell-enriched, low-density cells at the interface were collected,
washed, and plated on 60-ram tissue culture dishes (Falcon Labware) aLlowingtwo to three spleen equivalents per plate. After 90
min at 37~ the nonadherent ceLls,mainly lymphocyte, were removed by pipetting over the plates with warm RPMI. The adherent cells were cultured overnight in medium at 37~ Dendritic
cells, which become nonadherent upon culture, were collected and
contaminatingmacrophagesremovedby readheringthe cells to tissue
culture plates for 1 h at 37~ Dendritic cells purified in this
manner were 90-95% pure and contaminated primarily with a few
B cells (25).
Cell Lines. The P815 mastocytoma (H-2a) and the L929
fibroblast lines (H-2k) were grown in DME (Gibco Laboratories)
supplemented with 5% FCS, penicillin, streptomycin, and gentamicin. To use the L929 cells as targets in 51Crrelease assays, they
were detached by treating with 0.025% trypsin and cultured overnight in medium in bacteriologic dishes to which they do not adhere. An L929 cell line transduced with the influenza NP gene
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stricted CTLs from quiescent precursors. Dendritic cells are
potent stimulators of class II-restricted T cell responses to
a variety of antigens in vitro and in vivo, and can stimulate
vigorous CTL responses to influenza (13) and other viruses
(14-16). To approach the mechanism of dendritic cell function, we have studied the development of influenza-specific
CTLs. Two major issues have interested us. The first is whether
splenic dendritic cells must support endogenous viral protein synthesis to stimulate CD8 + CTLs, or can these APCs
present viral antigens using the exogenous processing pathway?
Recent reports suggest that APCs exist within the spleen
with the capacity to present native OVA to class I-restricted
CTLs (17, 18), and other studies have documented the presentation of class I-restricted minor antigens carried on donor
cells by host APCs (19, 20). A second area of interest is the
role of helper T cells. Dendritic calls can support the generation of allospecific CD8 + CTL in the absence of CD4 +
hdper T cells (21-23). We show here that viral protein synthesis and helper T cells are both significant quantitative elements in the dendritic cell-mediated induction of influenzaspecific CTLs in vitro.
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cytospun in a Cytospin 2 cytocentrifuge (Shandon, Sewickley,PA)
and stored with dessicant at -20~ The slides were brought to
room temperature, fixed in acetone for 10 min, incubated with hybridoma supematant for 45-60 rain, washed, and then incubated
with a 1:500 dilution of affinity-purified peroxidase-conjugated
rabbit anti-mouse IgG (H + L) (Zymed Laboratories, San Francisco, CA) for 45-60 rain. The cytospins were washed in PD/I%
BSA and incubated with substrate, 3,3'-diaminobenzidine tetrahydrochloride(Polysciences,Inc., Warrington, PA). After 7-10 rain
the slides were washed and mounted in PD-glycerol. The mAbs
to influenza proteins were kindly provided by Dr. J. Yewdell(National Institutes of Health) and included anti-NP (H16-L10-4R5;
ATCC HB65), anti-HA (H28E23), and anti-NS1 (29).
11"2 and 11,6 Assays. Serialdilutions of conditioned medium
were prepared and added to microwellscontaining 5 x 103 CTLb2
cells (1"b2)or 7TD1 cells (Ib6). After 24 h, the cultures were pulsed
with 1 #Ci/well of [3H]thymidinefor 8-12 h and units calculated
relative to standard recombinant lymphokines.

Results

The Capacitr of Dendritic Cells to Induce Influenza.specific
CTL. Recent studies have demonstrated that mouse spleen
dendritic ceils are potent stimulators of the CTL response
to influenza (13). We made similar observations using responding T cells that had been extensively depleted of APCs
(see Materials and Methods). When compared with a standard APC population of bulk spleen cells, virus-pulsed dendritic cells were ~100 times more efficient as stimulators (Fig.
1 A). A significant response was generated even when the
dendritic cell/T cell ratio was as low as 1:1,000. No CTLs
were induced with virus-pulsed splenic B cells, T cells, or
peritoneal macrophages (data not shown).
Contaminants within the enriched dendritic cell preparation could conceivably be responsible for the stimulation of
CTLs. However, removal of the trace B cell contaminants
with mAb RA3-6B2.1 plus complement did not diminish
the stimulatory capacity, while removal of dendritic cells with
33D1 plus complement dramatically reduced APC function
(data not shown) as in other T-dependent responses (30, 31).
In additional experiments, which are not shown, we verified
that the killer cells induced by dendritic cells in culture were
typical of CTLs generated in more heterogeneous systems.
Specifically, the killer cells were sensitive to lysis with antiThy-1 or anti-CD8 mAbs and complement, but not antiCD4 mAbs and complement. The CTL response was directed
in large part to epitopes in the viral NP, since targets coated
with the dominant NP147-155 peptide were recognized as
efficiently as virus-infected targets.
It could be argued that viral antigens released by the infected dendritic cells were presented by contaminating APCs
within the responder T cell population. To test this possibility, T cells from primed (C3H x DBA/2)Ft mice (H-2 k
• H-2 d) were restimulated with virus-pulsed dendritic ceils
prepared from either parental or F1 strains. We then measured lysis on both H-2 k (L929) and H-2 a (P815) targets.
When F1 responders were stimulated with F1 dendritic ceils,
we detected the lysis of both L929 and P815 targets (Fig.
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via a retroviral vector was kindly provided by Dr. E. Gilboa and
colleagues (Sloan-Kettering Institute, New York).
Infection of Cells with Influenza In Vitro. APCs and targets were
resuspended in serum-free RPMI at 107 cell/ml, containing 1,000
HAL/of virus/ml, for 90 min at 37~ In the case of freshly isolated dendritic cells, the low-density adherent spleen cells were infected by adding serum-free tLPMI plus virus directly to the plate.
To test if influenza infection required an acidic compartment, the
cells were incubatedin ammonium chloridefor 30 min before adding
virus and throughout the subsequent infection (26). 30 and 10 mM
NH4C1 blocked infection in P815 and dendritic cells, respectively.
The block was reversible upon removing the NH4C1, as assessed
by staining the cells for newly synthesized viral protein.
Generationof CTLs. PurifiedT cells from virus-primed animals
(1-3 x 10S/well) were cultured with graded doses of APCs in
round-bottomed 96-well tissueculture plates (Coming Ghss Works,
Coming, NY) in a total volume of 200 gl medium. The APCs
were irradiated with a 137Cssource (1,000 rad for primary APCs
and 10,000 tad for cell lines). After 5-6 d of culture, CTL activity
was assayed by SaCr-release from P815 (H-2a) and L929 (H-2k)
targets. When viable cell counts were obtained, specific cytotoxicity of 80-100% was obtained at E/T ratios of 30:1.
Cytotoxicity Assay. 2 x 106 targets at a concentration of 107
cells/ml in serum-freeRPMI were labeled with 100 #Ci NaSlCrO4
(New England Nuclear, Boston, MA) and simultaneously infected
with 200 HALl PR8 virus for 2 h at 37~ The targets were washed
four times and resuspended in medium at 4 x 10s cells/ml. 50
#1 of targets (2 x 104 cells) was added to each microwell in triplicate. Spontaneousand total release samples were preparedby adding
the targets to wells containing only RPMI or 0.2% SDS, respectively. The plates were centrifuged at 100 g for 5 min and incubated
at 37~ for 5 h. 25 gl of supematant was collected, deposited onto
a glass fiber filter mat, and counted in a Betaplate Liquid Scintillation Counter (LKB Wallac, Wallac Oy, Finland). Percent specific
S~Cr release was calculated as follows: 100x (releaseby CTL spontaneous release)/(total release - spontaneous release). Spontaneous release was generally 10-15% of the total release.
T Cell ProliferationAssay. T cells (3 x 10S/well)were cultured
in flat-bottomed microwells with graded doses of APCs. After
72-80 h, proliferation was assessed by pulsing the cultures with
1/~Ci/well [3H]thymidine (ICN Radiochemicals,Irvine, CA) for
8-16 h. The plates were harvested using an Automatic Harvester
(Skatron Inc., Sterling, VA), and the radioactivity was bound to
filters counted in a Betaplate counter.
Preparation ofLymphokine-rich Supernatant. 3 x 106 CD4 + T
ceils were combined with 10s allogeneic dendritic calls in 16-ram
macrowells. Supernatants were collected after 60-72 h and contained 50-100 U IL-2/ml.
Nucleoprotein Peptides. Peptides corresponding to residues
147-155 (TYQRTRALV) and 147-161 (TYQRTRALVRTGMDP)
of the 1968 influenza NP (27) were synthesized with the solidphase procedure (28) using the tertbutoxycarbonyl chemistry on
0.5 g of Boc-aminoacyl-OCH2-Pam resin (Applied Biosystems,
Inc., Foster City, CA). The peptide was cleavedoff from the resin
support by the high hydrofluoric acid (HF) method and purified
using reverse-phase Ca8 on a preparative column eluted with a
linear gradient from 5-60% of acetonitrile at a flow rate of 15
ml/min. The major peak was pooled. The acetonitrile was removed
and lyophilized to give a white powder. Amino acid analyses of
both peptides after 6 N HC1 hydrolysis were in good agreement
with the theoretical values of the peptide sequences.
Immunohistochemistry. Suspensionsof 3-10 x 103 ceUs/mlwere
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Figure 2. Dendritic ceils pulsed with bromdain-treated or UV-inactivated
virus do not stimulate class I-restricted CTL but do induce proliferation
of purified CD4 + T cells. Dendritic cells were incubated overnight with
no addition, 1,000 HAU/ml purified virus, bromelain-treated virus, or
UV-inactivated virus. The number of the different virus particles added
to the APCs was equivalent. (.4) 105 virus-primed T cells were cultured
with graded doses of APCs, and cytotoxicity was assayed on uninfected
(O) and infected ( e ) 1'815 targets. (B) 3 x 105 T cells from unprimed
(/eft), NT60-primed (m/rid/e), and PR8-primed (right) mice were stimuhted with dendritic cells pulsed with the following: no virus (O), infectious virus (e), bromelain-treated virus (W), and UV-inactivated virus
(m). The cultures were pulsed with [SH]thymidine from 80 to 92 h.
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theoretically be derived either from the input virus or from
proteins newly synthesized within the APCs. To explore these
alternatives, we compared presentation of wild-type influenza
with two types of noninfectious virus. UV irradiation blocks
viral RNA replication, while bromelain proteolyticaUy removes the external glycoproteins, including the HA that is
essential for fusion with intracellular membranes and virus
entry. These forms of noninfectious influenza did not yield
viral progeny, as determined using a modified plaque assay
with MDCK cells, and did not direct viral protein synthesis
in P815 cells as detected by staining with antiviral mAbs (see
below).
Dendritic cells pulsed with UV-inactivated virus did not
stimulate a strong CTL response (Fig. 2 A). At the highest
dose of APCs, there was a low level of specific lysis on infected target ceils ranging from 5% to 25%, but in all experiments, dendritic cdls pulsed with infectious virus were
much more potent than APCs pulsed with UV-inactivated
virus. Dendritic cells pulsed with bromdain-treated virus also
failed to stimulate influenza-specific CTLs (Fig. 2 A). The
UV- and bromelain-treated virus did not contain "preprocessed" peptides, since neither could sensitize targets for lysis
by CTL (data not shown).
The inability of dendritic cells to present noninfectious virus
to class I-restricted T cells could reflect poor internalization
of viral antigens. However, dendritic cells readily presented
either U-V-inactivated or bromelain-treated virus to class II-re-

Dendritic Cell Mechanism of Inducing Virus-specific CTLs
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Figure 1. Dendritic cells are potent
stimulators of influenza-specific CTLs.
(.4) 3 x 105 purified T cells from
virus-primed C x D2 mice were cultured with graded doses of infected
spleen cells (O and e ) or d~dritic cells
(rl and II). After 5 d, CTL activity
was assayed with uninfected (0 and I-])
and infected ( e and II) P815 targets.
(B) T cells were prepared from the
spleens of virus-primed (C3H x
DBA/2)F1 (C3 x D2) animals. 3 x
105 T cells were cultured with graded
doses of infected DBA/2 (H-2d; left),
C3H (H-2~; middle), or C3 x D2
(right) dendritic cells. Cytot~wJcity was
assayed on uninfected (opensymboh) and
infected (filled symbols) L929 (H-2k; A
and A) and 1'815 (H-2a; O and O)
targets.

Visualization of Viral Uptake and Infection in Dendritic
Cells. We used immunocytochemical techniques to determine directly if dendritic cells were capable of supporting
the synthesis of influenza proteins. Standard direct metabolic
labeling methods using [3SS]methionine did demonstrate the
synthesis of NP in infected dendritic cells (data not shown),
but the approach was not pursued because very large numbers
of dendritic cells (5 x 106) were needed for each experiment. Instead, we found that dendritic cells exposed to infectious virus could be stained positively with mAbs to the
influenza NP or HA. Both mAbs stained the dendritic cells
diffusely, consistent with endogenous viral protein synthesis

(Hg. 3, A and B). The number of positively stained cells varied,
ranging from 20 to 50%. We also stained the cells with a
mAb to the nonstructural protein, NSL NS1 is not part of
incoming virions but is a vitally encoded protein synthesized
within infected ceUs. The NS1 staining consisted of granular
deposits in the nucleus (Fig. 3 C). Control studies indicated
that infected dendritic cells did not stain with an isotypematched antibody against human CD8 (Hg. 3 D). Uninfected
dendritic cells did not stain with any of the mAbs tested (data
not shown).
We were not able to detect the uptake of influenza virus
particles by light microscopy. However, when infection was
blocked with ammonium chloride (32), which neutralizes
acidic resides needed for viral envelope fusion and delivery
of KNA to the cytoplasm, the dendritic cells accumulated
dense granules that stained with anti-NP mAb (Fig. 3 E)
We presume the granules represent endocytic vesicles that
were neutralized with ammonium chloride. Similarly, when
we exposed dendritic cells to bromdain-treated virus overnight, the cytoplasm again contained granules of anti-NP antibody staining, and the number of these granules increased
if ammonium chloride was added (Fig. 3 F). If dendritic cells
were pulsed with UV-inactivated virus, there was no diffuse
staining with mAbs to NP and HA (data not shown). Therefore, influenza seems to gain access to dendritic ceils via an
acid-dependent endocytic route, although for unknown
reasons, only a fraction of the APCs show detectable levels
of viral protein synthesis.

The Role of CD4 + Helper Cells and Lymphokine in the Induction of CTLs. Primed CD4 + T cells proliferate vigorously to both infectious and noninfectious influenza (Fig.

Figure 3. Detection of influenza NP, HA, and NS1 proteins in infecteddendritic cells. Dendritic cells were incubated with virus for 90 min and
then cultured for 16 h. C~os.pins were prepared and stained with the following mAbs: anti-HA (A), anti-NP (B), anti-NS1 (C), and anti-human
CD8 (D). tn c,, the NS1 stmmng is contmed to the nucleusand consistsof granular deposits(arrows).In E, dendritic ceUswere infectedin the presence
of 10 mM NI-I4C1for 16 h and stained with anti-NP mAb. In F, cells were pulsed with bromehin-treated virus for 16 h in the presence of 10 mM
of NH4C1, and were stained with anti-NP mAb. In both E and F, granular presumptive endocyticvesiclesare seen (arrows)( x 500).
523
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stricted T cells, as evidenced by strong proliferative responses
of purified CD4 + T cells (Fig. 2 B). In fact, dendritic cells
pulsed with noninfectious virus stimulated the proliferation
of CD4 + T cells almost as effectivdy as dendritic ceils exposed to infectious virus (Hg. 2/3). The response was blocked
by >80-90% with anti-class II or anti-CD4 mAbs (data not
shown).
Unprimed CD4 + T cells did not proliferate in response
to infected dendritic cells (Figs. 2 B, left). Superantigens can
stimulate unprimed T cells, so our data suggests that influenza
virus does not carry significant superantigens for BALB/c x
DBA/2 T ceils. The hdper T cell iesponse we observed was
for the most part crossreactive (Fig. 2 B). T cells prepared
from mice primed with the NT60 strain (H3N2 subtype)
or the PK8 strain (H1N1 subtype) responded similarly to
antigens in PR8 virus, including bromdain-treated virus. We
conclude that internal virion components in noninfectious
influenza are presented in a potent fashion to CD4 + but not
CD8 + T cells.
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sistent with the fact that GK1.5 did not completely block
CO4 proliferation to infected APCs (data not shown).
Capacity of Class II-Negative Cells to Stimulate CTL. The
above data suggested that one reason for the intense stimulatory capacity of dendritic cells is their capacity to stimulate
class II-restricted helper T cells and the production of requisite lymphokines. We therefore tested the APC function of
cells that lack class II MHC molecules, choosing the P815
cell line, since this line acts as a target for dass I-restricted
CTLs. In contrast to dendritic cells, infected P815 cells did
not stimulate CTL development from inactive precursors (Fig.
5 A). P815 cells functioned as excellent stimulators when supplemented with a lymphokine-rich supernatant.
We observed similar results when we used the H-2 k L929
cell line as the stimulator. Here, instead of using infected cells,
we used a variant that had been transduced with the influenza
NP gene carried by a retroviral vector (34). By using this
L929-NP cell line, we could rule out any inhibitory effects
of influenza virus, a cytotoxic virus, on APC function.
L929-NP cells were stained positively with anti-NP mAb (data
not shown) and were efficiently lysed by H-2k-restricted
CTLs; however, NP-expressing L cells were poor stimulators
of a CTL response unless supplemented with exogenous lymphokines (Fig. 5 B).
Stimulation of CTLs with a Synthetic NP Peptide. Given
the need for CO4 + helper cells, it seemed unlikely that dendritic cells pulsed with a class I-restricted NP peptide could
direct the formation of CTLs. This proved to be the case
with either NP147-161 or NP147-155 peptides. CTLs could
only be induced by peptide-pulsed APCs if the cultures were
supplemented with lymphokines (Fig. 6 A). These findings
suggested that dendritic cells pulsed with peptide were poor
stimulators of helper lymphokine production. To assess this
directly, we examined the production of II~2 and I1,-6, which
have been shown to enhance CTL development by dendritic
cells (35). Virus-infected dendritic cells stimulated high levels
of Ib2 and ID6 secretion from bulk T cells, but peptide-pulsed
dendritic cells were inactive (Fig. 6 B). It is to be pointed
out that at higher APC doses, both infected and uninfected
dendritic cells induce a significant syngeneic MLK from
primed or unprimed CD4 + T cells, resulting in the production of helper lymphokines (36).

0
'~
Q

50-

Discussion

(..)
25.

i

10z

v

v v

T

103

10 ~

Dendritic Cell Dose

Figure 4. Induction of influenza-specificCTLs by dendritic cells requires
functional CD4 + helper cells or their lymphokine products. (A) 105 bulk
T or CD8 + T cells were cultured with graded doses of infected dendritic
cells. (B) 3 x 10s purified T cells were cultured with graded doses of dendritic cells in flat-bottomed wells. The control mAb to Thy-1, B5-5, and
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The recognition of viral antigens by CTLs has been studied
intensively, so that presentation of viral peptides on MHC
class I products is now understood in some detail (11). In
such studies, the CTLs have already been activated, typically
as long-term cell lines or in the case of primary cultures, by
stimulating heterogeneous cell populations with virus and
exogenous lymphokines. In this report, we have confirmed
prior findings that dendritic cells are specialized APCs for
generating virus-specific CTLs from inactive precursors
(13-16). Given the apparently critical role of dendritic cells
in inducing CTLs (Fig. 1), we have focused on two aspects
of mechanism: the need for viral protein synthesis and the
contribution of helper T cells.
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2 B). The role of CD4 + helper cells in influenza-specific a n tibody response is established, but we wished to evaluate the
importance of helper T cells and lymphokines in the CTL
response. In prior studies of all9
CTLs, CD4 + helper
cells were not required when dendritic cells were the APCs
(21-23).
When purified CO8 + T cells (see Materials and Methods)
were stimulated with infected dendritic cells, little (10-20%
killing) or no induction of virus-specific cytotoxicity was
observed (Fig. 4 A). The response could be restored by
adding a lymphokine-rich supernatant to the culture. The
required soluble factors were not antigen specific since they
could be generated in dendritic cell-CD4 + T cell, allogenic
MLRs (33).
The importance of CD4 + T cells for the generation of
virus-specific CTLs could be demonstrated using blocking
mAbs (Fig. 4 B). Anti-CD4 mAb GK1.5 significantly reduced the response, and the block was reversed by adding
exogenous lymphokines. At the highest stimulator dose,
GK1.5 did not totally block the CTL response. This is con-
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Synthesis within

Dendritic Cells.

M H C class I molecules acquire peptides derived from the proteolysis of antigens within the cytoplasm (reviewed in reference 37). A pathway for the presentation of exogenous proteins on class I, without the need for de hove synthesis of
the antigen within the APC, has also been described (17,
18). We wondered if dendritic cells, being specialized APCs,
had such a mechanism for charging class I M H C in the absence of de nero viral protein synthesis. If exogenous processing could occur, dendritic cells would not have to be infected to act as APCs for many different viruses.
However, an exogenous pathway could not be demonstrated.
In agreement with the findings ofMorrison et al., and Bradale
and Yap (12, 38) in other cells, U V inactivation of the virus,
which inhibits viral replication and protein synthesis, led to
a dramatic reduction in presentation (Fig. 2). Dendritic calls
also did not present bromdain-treated virus, which lacks the
H A needed for the delivery of viral R N A into the cytoplasm.
The UV- and bromelain-treated forms of influenza were taken
up efficiently, because dendritic cells pulsed with these exogenous viral antigens stimulated vigorous proliferation of
C D 4 + T ceils (Fig. 3). Therefore, dendritic cells do not appear to possess an alternative processing pathway by which
exogenous antigens can be presented on class I M H C molecules. Nair et al. (39) have recently demonstrated that exogenous antigens can be presented by dendritic cells only if delivered directly to the cytoplasm using add-sensitive liposomes.
It is not yet clear if this pathway can deliver sufficient quantities of antigen to generate CTLs as efficiently as infectious
virus.

Helper Cell Requirements and the Immunogenicity of Class
1-restricted Peptides. A second issue relates to the need for
helper T ceils during dendritic cell-mediated C T L development. Prior data in the allogeneic M L R showed that dendritic cells could induce CD8 + CTLs in the apparent absence
of helper ceils (21-23). C D 4 + helper T ceils are k n o w n to
potentiate virus-specific C T L responses in vitro (40) and in
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mice were cultured with graded doses of L929-NP stimulators. (Right) Cultures were supplemented with 25% allogeneic MLR supernatant. After
5 d cytotoxicity was assayed on uninfected (open symbob) and infected (filled symbols) L929 (H-2~; triangles) and P815 (H-2d; circles) targets.
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dritic cell class I molecules via the endogenous route, and/or
live influenza may affect APC adhesion molecules and
costimulatory functions.
Previous studies of influenza-specific helper T cells have
focused on external proteins as antigens, particularly the viral
HA. Both strain-specific and broadly crossreactive hdper epitopes have been described (58-60). By priming mice in vivo
with the NT60 strain (H3N2) and then restimulating in vitro
with the PR8 strain (H1N1), we generated T cells responding
to determinants shared between virus strains; therefore, hdp
had to be derived from crossreactive helper T cells. Indeed,
bromelain-treated virus that lacked envelope proteins stimulated the vigorous proliferation of crossreactive CD4 + T
cells (Fig. 3). The influenza-specific, crossreactive CD4 + T
call response is a powerful one. It can be detected in spleen
after intranasal priming, whereas most studies on murine
helper T cell responses require the use of draining lymph nodes
and local foot pad immunization. Also, the helper response
persists for months after infection, whereas lymph node
priming wanes in weeks.
Pathwaysfor Generating CTL In ViM During the course
of infection, influenza productively infects the epithdial cells
lining the respiratory tract, and 3-7 d later, influenza-specific
CTLs can be detected in lung tissue and in the airway (61).
There are several possible mechanisms for the generation of
these CTLs in vivo. First, CTLs may be induced by virus-infected, respiratory epithelial cells. However, class II-negative
cell lines cannot stimulate CTLs in vitro without lymphokines
derived from activated CD4 + T cells (Fig. 5). Although infected epithdial ceils can probably be lysed by CTLs, their
lack of class II MHC molecules, and/or the inability to activate CD4 + helper T cells, could obviate the induction of
CTL responses.
A second possible pathway is that dendritic cells acting
alone initiate influenza-specific CTLs. Dendritic cells can acquire antigens in the lung (62), where the APCs form an
impressive array in the airway epithelium (63), much like the
dendritic ceils of the epidermis. Dendritic cells in the respiratory tract, like those in other tissues, may migrate to the
draining lymph nodes (64), where they can present viral antigens simultaneously to dass II-restricted helper T ceils and
to class I-restricted CTL precursors found in the recirculating
pool of quiescent lymphocytes.
A third pathway, which pertains more to viruses that do
not infect dendritic cells, has two stages in which dendritic
ceils take up virus and stimulate helper T cells. The latter
synthesize the lymphokines needed for the development of
CTL by those infected, class I-expressing cells, which are
the natural targets for a given virus. Since dendritic cells are
potent inducers of helper T ceils that are broadly crossreactire (Fig. 2 B), this pathway might be exploited to generate
more effective vaccines to influenza. Crossreactive helper T
cells can secrete the antiviral agent IFN-3,, augment the
production of CTLs as described here, and amplify the formation of neutralizing antibodies through the mechanism
of intermolecular help (65).
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vivo (41-43), although prior studies were not carried out using
dendritic cells as stimulators.
We noted a marked amplification of the CTL response to
virus in vitro by CD4 + helper T cells and their lymphokine
products, even when dendritic calls were used as stimulators
(Fig. 4). The hdper factors were antigen nonspecific, since
active factors were present in supernatants derived from
CD4 + T calls that were not primed with influenza but instead were stimulated with allogeneic APCs. There are contrasting studies in which virus-specific CTL develop in the
absence of CD4 + T cells (44-47). Possibly helper cells are
not essential but accelerate the CTL response, allowing the
host to develop resistance more quickly or in the face of larger
viral inocula. Stimulated CD8 + cells can secrete Ib2 and
IFN-3, (48-50), but the adequacy of lymphokine secretion
may be influenced by the proportion of responding T calls.
In a CD4-independent MLR, >1% of the CD8 + cells respond to antigens presented by dendritic cells. These large
numbers may produce enough lymphokine to provide help
(22). In contrast, only 1:14,000 to 1:2,400 of influenza-primed
populations are responsive to influenza antigens (51, 52).
We also examined the stimulatory capacity of cells that
could not stimulate class II-restricted T cell hdp. Class
II-negative cell lines, either infected with live virus or transduced with the gene for influenza NP, were tested as APCs.
A need for helper lymphokines was observed (Fig. 5), even
though these cells were excellent targets for mature CTLs
induced by dendritic cells. Similarly, dendritic cells, when
pulsed with peptides that could be presented on class I but
not class II MHC molecules, did not induce CTLs (Fig. 6
A) or helper lymphokines (Fig. 6 B). Our studies indicate
that an important mechanism of dendritic cell function is
the capacity to present antigens to both CD8 § cytotoxic and
CD4 + hdper T cells.
The direct stimulation of class I-restricted CTLs with peptide appears to be difficuh. The NP147-161 peptide, as well
as peptides representing other CTL epitopes, fail to prime
CTLs in vivo (53-55). Recently, two groups studied in vivo
priming of CTLs with peptides derived from the lymphocytic choriomeningitis virus and influenza NPs (56, 57). Both
concluded that responses required CD4 + helper T cells. In
some instances, peptides that are effective immunogens are
longer than those required to sensitize targets for lysis by
CTLs (54). Perhaps increasing the length has included a helper
epitope.
Although the addition of lymphokines increased the potency
of peptide-pulsed dendritic cells, these stimulators were never
as efficient as virus-infected dendritic cells (Fig. 6 A). When
we added lymphokines to T cells that had been stimulated
by infected APCs in the presence of anti-CD4 blocking mAbs,
we were able to restore vigorous CTL responses (Fig. 4 B).
Surprisingly, our preliminary data are that the concentration
of peptide required by dendritic ceils for presentation to developing CTLs is >1,000 times greater than that required
to sensitize target cell lines for lysis by mature CTLs. Infectious virus likely differs from peptides as a means for charging
APCs with antigen. More peptide may gain access to den-
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